Application of microarray in breast cancer: An overview

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 1, 2012, Pages 21-26

  Kumar, Rajnish ^a   Sharma, Anju ^a   Tiwari, Rajesh Kumar ^a  

^a AMITY UNIVERSITY   (India)

Author keywords

Breast cancer; DNA; genome; microarray

Indexed keywords

ARTIFICIAL NEURAL NETWORK; BREAST CANCER; CHROMOSOME REARRANGEMENT; CLINICAL DECISION MAKING; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENOMICS; HUMAN; KARYOTYPE; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TAXONOMY; TISSUE MICROARRAY;

EID: 84863399749     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.92726     Document Type: Review

References (56)

1. Park Y, Shackney S, Schwartz R. Network-based inference of cancer progression from microarray data. IEEE/ACM Trans Comput Biol Bioinform 2009;6:200-12.
2. Dumitrescu RG, Cotarla I. Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 2005;9:208-21.
3. Honrado E, Osorio A, Palacios J, Benitez J. Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006;25:5837-45. (Pubitemid 44453439)
4. Sorliiea T, Peroua CM, Tibshiranie R, Aasf T, Geislerg S, Johnsenb H, et al. Gene experimentation pattern of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-74.
5. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey S, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
6. Chang J, Hilsenbeck S, Fuqua S. The promise of microarrays in the management and treatment of breast cancer. Breast Cancer Res 2005;7:100-4. (Pubitemid 40704129)
7. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, et al. Estrogen receptor status in breast cancer is associated with remarbly distinct gene expression patterns. Cancer Res 2001;61:5979-84. (Pubitemid 32762524)
8. Mackay A, Weigett B, Grigoriadis A, Kreike B, Natrajan R, A'Hern R, et al. Microarray based class discovery for molecular classification of breast cancer: Analysis of interobserver agreement. J Natl Cancer Inst 2011;103:662-73.
9. Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: A population-based cohort study. BMC Cancer 2011;11:292.
10. Al-Ejeh F, Smart CE, Morriosn BJ, Chenevix-Trench G, Lopez JA, Lakhani SR, et al. Breast cancer stem cells: Treatment resistance and therapeutic opportunities. Carcinogenesis 2011;32:650-8.
11. Cheang MC, van de Rijn M, Nielsen TO. Gene expression profiling of breast cancer. Annu Rev Pathol 2008;3:67-97. (Pubitemid 351492437)
12. Sheen-Chen SM, Zhang H, Huang CC, Tang RP. Insulin-like growth factor-binding protein-3 in breast cancer: Analysis with tissue microarray. Anticancer Res 2009;29:1131-5.
13. Kao KJ, Chang KM, Hsu HC, Huang AT. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: Implications for treatment optimization. BMC Cancer 2011;18:143.
14. Xu J, Chambers AF, Tuck AB, Rodenhiser DI. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis. Cancer Genet Cytogenet 2008;181:1-7. (Pubitemid 351192030)
15. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6. (Pubitemid 34130608)
16. Sadikovic B, Andrews J, Carter D, Robinson J, Rodenhiser DI. Genome wide H3K9 histone acetylation profiles are altered in benzopyrene treated MCF7 breast cancer cells. J Biol Chem 2008;283:4051-60.
17. Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, et al. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res 2008;10:R62.
18. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-9. (Pubitemid 40260888)
19. Weigelt B, Hu Z, He X, Livasy C, Carey LA, Evend MG, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 2005;65:9155-8. (Pubitemid 41507977)
20. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183-92. (Pubitemid 44390989)
21. Welch DR. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res 2004;6:61-4. (Pubitemid 38324843)
22. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-24. (Pubitemid 41112921)
23. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49. (Pubitemid 36808649)
24. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006;7:96.
25. Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, et al. A consensus prognostic gene expression classifier for ER positive breast cancer. Genome Biol 2006;7:R101.
26. Liu R, Wang X, Grace YC, Dalerba P, Gurney A, Hoey T, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217-26. (Pubitemid 46143225)
27. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005;102:3738-43. (Pubitemid 40354681)
28. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38:1043-8. (Pubitemid 44325930)
29. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006;98:262-72. (Pubitemid 43264710)
30. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59.
31. Esteller M. Cancer epigenomics: DNA methylomes and histone modification maps. Nat Rev Genet 2007;8:286-98. (Pubitemid 46439286)
32. Rodenhiser DI, Andrews J, Kennette W, Pilon J, Hodgson A, Tuck AB, et al. Mutli-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PLoS ONE 2010;5:e8665.
33. Duenwald S, Zhou M, Wang Y, Lejnines S, Kulkarin A, Graves J, et al. Development of a microarray platrform for FFPET profiling: Application to the classification of human tumors. J Transl Med 2009;7:65.
34. Lih C, Li Y, Trinh L, Chien S, Wu X, Liu W, et al. Breast cancer patients stratification by microarray-based gene expression profiling from FFPET samples. J Clin Oncol 2009;27:e22041.
35. Ramaswamy S. Translating cancer genomics into clinical oncology. N Engl J Med 2004;350:1814-6. (Pubitemid 38917246)
36. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, et al. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 2009;4:e8162.
37. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000;24:1016-9. (Pubitemid 30430490)
38. Farragher SM, Tanney A, Kennedy RD, Paul Harkin D. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol 2008;130:435-45.
39. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999;27:4436-43. (Pubitemid 29533185)
40. Scicchitano MS, Dalmas DA, Bertiaux MA, Anderson SM, Turner LR, Thomas RA, et al. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J Histochem Cytochem 2006;54:1229-37. (Pubitemid 44623343)
41. Song XC, Fu G, Yang X, Jiang Z, Wang Y, Zhou WG. Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining. Mol Cell Proteomics 2008;7:163-9. (Pubitemid 351248241)
42. Glass AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006;7:278.
43. Bose S, Chandran S, Mirocha JM, Bose N. The Akt pathway in human breast cancer: A tissue-array-based analysis. Mod Pathol 2006;19:238-45. (Pubitemid 43117608)
44. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-23. (Pubitemid 36842560)
45. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004;15:2523-36. (Pubitemid 38691844)
46. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 2005;24:4660-71. (Pubitemid 41032603)
47. Smith DD, Saetrom P, Snove O Jr, Lundberg C, Rivas GE, Glackin C, et al. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bioinformatics 2008;9:63.
48. Thomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat 2009;113:239-49.
49. Moreau Y, Aerts S, De Moor B, De Strooper B, Dabrowski M. Comparison and meta-analysis of microarray data: From the bench to the computer desk. Trends Genet 2003;19:570-7. (Pubitemid 37204916)
50. Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002;62:4427-33. (Pubitemid 34827303)
51. Choi JK, Yu U, Kim S, Yoo OJ. Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 2003;19 Suppl 1:i84-90. (Pubitemid 41185603)
52. Warnat P, Eils R, Brors B. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics 2005;6:265.
53. Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, et al. Resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer 2008;8:396.
54. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J. GOBO: Gene expression-based Outcome for Breast cancer Online. PLoS One 2011;6:e17911.
55. Gyorffy B, Benke Z, Lanczky A, Balazs B, Szallasi Z, Timar J, et al. Recurrence online: An online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat 2011 In press.
56. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010;123:725-31.